Go to Top

Blog Archives

Tag Archives: BCRX

BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. BioCryst announced that it received a preliminary comment letter from the FDA that outlines a pathway by which BioCryst could file a New Drug Application (NDA) seeking regulatory approval of its drug candidate intravenous …Read More